Spots Global Cancer Trial Database for Observational Study of Pertuzumab Safety in Participants With Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Observational Study of Pertuzumab Safety in Participants With Breast Cancer
Official Title: Post-Marketing Surveillance of Perjeta in Breast Cancer
Study ID: NCT02266173
Conditions
Interventions
Study Description
Brief Summary: This Phase IV, prospective, multicenter, non-interventional study (regulatory post-marketing surveillance) will evaluate the safety of pertuzumab in approximately 1000 participants with metastatic or locally unresectable recurrent breast cancer who have never received chemotherapy or anti-human epidermal growth factor receptor 2 (HER2) therapy for their metastatic disease with HER2 positivity in Korea. Participants who are administered with pertuzumab according to medical opinions of the doctor in charge of surveillance will be registered for this study and treated with pertuzumab under the approval conditions of the product in Korea.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Inje university Haeundae Paik Hospital, Busan, , Korea, Republic of
Pusan National University Hospital, Busan, , Korea, Republic of
Kosin University Gospel Hospital, Busan, , Korea, Republic of
Kyungpook National University Chilgok Hospital, Daegu, , Korea, Republic of
Keimyung University Dongsan Medical Center, Daegu, , Korea, Republic of
Chungnam National University Hospital, Daejeon, , Korea, Republic of
National Health Insurance Service Ilsan Hospital, Gyeonggi-do, , Korea, Republic of
Hallym University Sacred Heart Hospital, Gyeonggi-do, , Korea, Republic of
Soonchunhyang University Bucheon Hospital, Gyeonggi-do, , Korea, Republic of
St. Vincent's Hospital, Gyeonggi-do, , Korea, Republic of
Ajou University Medical Center, Gyeonggi-do, , Korea, Republic of
The Catholic University of Korea Bucheon St. Mary's Hospital, Gyeonggi-do, , Korea, Republic of
Pusan National University Yangsan Hospital, Gyeongsangnam-do, , Korea, Republic of
Catholic Univ. of Incheon St.Mary's Hospital, Incheon, , Korea, Republic of
Inha University Hospital, Incheon, , Korea, Republic of
Gil Hospital. Gachon University, Incheon, , Korea, Republic of
Catholic Kwandong University International St. Mary'S Hospital., Incheon, , Korea, Republic of
Chonnam National University Hwasun Hospital, Jeollanam-do, , Korea, Republic of
Wonkwang University School of Medicine & Hospital, Jeonlabuk-do, , Korea, Republic of
Seoul National University Bundang Hospital, Seongnam-si, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Inje University, Sanggye-Paik Hospital, Seoul, , Korea, Republic of
Korea Cancer Center Hospital of Korea Institute of Radiological and Medical Sciences, Seoul, , Korea, Republic of
Korea University Anam Hospital, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of
Konkuk University Medical Center, Seoul, , Korea, Republic of
Gangdong Kyung Hee University Hospital, Seoul, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Gangnam Severance Hospital, Seoul, , Korea, Republic of
Seoul St Mary's Hospital, Seoul, , Korea, Republic of
ChungAng University Hospital, Seoul, , Korea, Republic of
Yeouido St. Mary's Hospital, Seoul, , Korea, Republic of
Ewha Womans University Mokdong Hospital, Seoul, , Korea, Republic of
Korea University Guro Hospital, Seoul, , Korea, Republic of
SMG-SNU Boramae Medical Center, Seoul, , Korea, Republic of
Ulsan University Hosiptal, Ulsan, , Korea, Republic of
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
